UConn HealthThe Carole and Ray Neag Comprehensive Cancer Center


Commission on Cancer (COC) logoThe Neag Comprehensive Cancer Center is accredited by the Commission on Cancer of the American College of Surgeons. Commission on Cancer approval is given only to those institutions that have voluntarily committed to provide the best in diagnosis and treatment of cancer and to undergo a rigorous evaluation process and review of its performance. To maintain approval, institutions with approved cancer programs must undergo an on-site review every three years.

UConn Health first won Commission on Cancer approval in 1977 and has maintained that status ever since.

According to the Commission on Cancer, patients receiving care at an approved cancer program are ensured access to:

  • Comprehensive care, including a range of state-of-the-art services and equipment.
  • A multispecialty, team approach to coordinate the best treatment options.
  • Information about ongoing clinical trials and new treatment options.
  • Access to cancer-related information, education and support.
  • A cancer registry that collects data on type and stage of cancers and treatment results and offers lifelong patient follow-up.
  • Ongoing monitoring and improvement of care.
  • Quality care close to home.


What Is an Approved Cancer Program?

Hospitals, treatment centers, and other facilities are approved according to standards set by the Committee on Approvals of the Commission on Cancer.

The structure outlined in Standards of the Commission on Cancer Volume I: Cancer Program Standards ensures that each approved program provides all patients with a full range of diagnostic, treatment, and supportive services either on-site at the facility or by referral.

The Commission on Cancer encourages approved programs to improve the quality of their patient care by implementing multidisciplinary cancer programs that cover the following issues:

  • Prevention
  • Early diagnosis
  • Pretreatment evaluation
  • Staging
  • Optimal treatment
  • Rehabilitation
  • Surveillance for recurrent disease and multiple primary tumors
  • Psychosocial support
  • End of life care
A-Z INDEX        UCONN HEALTH        TEXT-ONLY UConn Health
Disclaimer   Privacy Notice
Maps & Directions